Healthcare / Health Information ServicesTokyo
$2220.00
-15.00 (-0.67%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 21%
FCF escenarios
weak_data · normalized FCF $418.2M · quality 41.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.9B
P/E
10.9x
↓EV/EBITDA
5.4x
↓ROE
10.7%
↑Gross Margin
77.0%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.8%
FCF CAGR
+19.7%
FCF margin
17.4%
FCF / Net income
0.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.41B · net income $448.1M · FCF $418.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.41B | $2.41B | $2.11B | $2.04B | $2.22B |
| Net Income | $448.1M | $448.1M | $401.8M | $258.5M | $316.3M |
| EBITDA | $638.0M | $638.0M | $500.8M | $299.3M | $465.2M |
| EPS | 201.13 | 201.13 | 180.35 | 116.03 | 141.96 |
| Gross Margin | 77.0% | 77.0% | 75.8% | 71.6% | 73.5% |
| Operating Margin | 22.8% | 22.8% | 20.0% | 11.3% | 18.8% |
| Net Margin | 18.6% | 18.6% | 19.0% | 12.7% | 14.3% |
| Balance Sheet | |||||
| Current Ratio | 5.87 | 5.87 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $418.2M | $418.2M | $490.6M | $-115.8M | $243.9M |
| Returns | |||||
| ROE | 10.7% | 10.7% | 10.2% | 6.9% | 8.8% |
| Valuation | |||||
| P/E | 10.94 | 10.94 | 10.60 | 14.60 | 12.98 |
| EV/EBITDA | 5.41 | 5.41 | 5.30 | 7.92 | 4.96 |
| P/B | 1.18 | 1.18 | 1.08 | 1.01 | 1.14 |
| Growth & Yield | |||||
| Revenue Growth | 13.9% | 13.9% | 3.5% | -7.8% | — |
| EPS Growth | 11.5% | 11.5% | 55.4% | -18.3% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-0.7%
EPS terminal req.
$196.99
Spread vs growth
12.2%
5Y implied EPS CAGR
3.5%
EPS terminal req.
$238.36
Spread vs growth
8.1%
10Y implied EPS CAGR
6.7%
EPS terminal req.
$383.87
Spread vs growth
4.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+9.4%
Start / end P/E
11.7x → 11.0x
EPS bridge
180.35 → 201.13
Residual
-0.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.